Both time-varying operation modes produce significant vibration control effects, with reductions of the resonance peaks of the target resonances or target frequency band up to 12 dB.
Targeted magnetic resonance imaging (MRI) has emerged as a promising diagnostic approach offering high resolution depictions of pathological anatomy and the detection of associated disease biomarkers [[1]-[3]].
Targeted magnetic resonance imaging (MRI) has emerged as a promising diagnostic approach that offers a high-resolution depiction of pathological anatomy and the ability to detect associated disease biomarkers [3, 4].
Recently superparamagnetic iron oxide nanoparticles (SPIONs) have been extensively used in cancer therapy and diagnosis (theranostics) via magnetic targeting, magnetic resonance imaging, etc. due to their remarkable magnetic properties, chemical stability, and biocompatibility.
Simulations of the resulting pulse transform Iz→0.995Ix over the target ranges in resonance offset and RF variability.
In the second step, IL-1β, TNF-α, IL-6, and GAPDH transcription in each sample was quantified in separate reactions on an Opticon2 DNA Engine (MJResearch, Waltham, MA, USA) using target-specific primers and a target-specific fluorescence resonance energy transfer (FRET) probe (Biosource, Camarillo, CA, USA).
Superparamagnetic iron oxide nanoparticles (SPIONs) are widely studied as platforms for smart biocompatible nanosystems which can be used for magnetic drug targeting and magnetic resonance imaging.
These functional composite NPs have been widely used in various fields, such as magnetic fluids, data storage, catalysis, target drug delivery, magnetic resonance imaging contrast agents, hyperthermia, magnetic separation of biomolecules, biosensor, and especially the isolation and recycling of expensive catalysts [2 12].
Using our cell surface engineering technology, mesenchymal stem cells (MSC s were modified with: 1) a homing peptide or a recombinant protein to facilitate the migration of the cells toward a specific molecular target; or 2) magnetic resonance imaging (MRI) contrast agents to allow for in vivo tracking of the cells.
